Literature DB >> 11012847

Drooling: review of the literature and proposals for management.

J H Nunn1.   

Abstract

The aetiology of drooling is described alongside the alternative treatment strategies for what is a disturbing disorder for many children. The advantages and disadvantages of each treatment modality are discussed. Conditions for optimal management are described.

Entities:  

Mesh：

Year:  2000        PMID： 11012847     DOI： 10.1046/j.1365-2842.2000.00575.x

Source DB:  PubMed          Journal:  J Oral Rehabil        ISSN： 0305-182X            Impact factor:   3.837


  7 in total

Review 1.  A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling.

Authors:  P H Jongerius; P van Tiel; J van Limbeek; F J M Gabreëls; J J Rotteveel
Journal:  Arch Dis Child       Date:  2003-10       Impact factor: 3.791

2.  Management of drooling in disabled patients with scopolamine patches.

Authors:  Abigail Mato; Jacobo Limeres; Inmaculada Tomás; Maria Muñoz; Concepción Abuín; Javier F Feijoo; Pedro Diz
Journal:  Br J Clin Pharmacol       Date:  2010-06       Impact factor: 4.335

3.  Anticholinergic treatment for sialorrhea in children: A systematic review.

Authors:  Peng You; Julie Strychowsky; Karan Gandhi; Breanna A Chen
Journal:  Paediatr Child Health       Date:  2021-08-27       Impact factor: 2.600

4.  Current Aspects of Treatment Options of Chronic Sialorrhea in Children.

Authors:  Stefan Bittmann; Elisabeth Luchter; Lara Bittmann; Elena Moschuring-Alieva; Gloria Villalon
Journal:  J Clin Med Res       Date:  2022-06-27

5.  Botulinum toxin in the treatment of drooling in tetraplegic patients with brain injury.

Authors:  Sung Hwa Ko; Yong Beom Shin; Ji Hong Min; Myung Jun Shin; Jae Hyeok Chang; Yong-Il Shin; Hyun-Yoon Ko
Journal:  Ann Rehabil Med       Date:  2013-12-23

Review 6.  Salivary gland diseases in children.

Authors:  Heinrich Iro; Johannes Zenk
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2014-12-01

Review 7.  Salivary Secretory Disorders, Inducing Drugs, and Clinical Management.

Authors:  Jaume Miranda-Rius; Lluís Brunet-Llobet; Eduard Lahor-Soler; Magí Farré
Journal:  Int J Med Sci       Date:  2015-09-22       Impact factor: 3.738
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.